Travera’s new technology can predict how patients will respond to hundreds of different drugs or drug combinations before the patients even take the drugs. Their new measurement tool, the Suspended Microchannel Resonator […]
Category: Consortium
Findings are recent published reports that our editors found interesting and relevant to investors and emerging companies.